Who Paid My Doc
Intracept
ClinicalTrials.gov NCT03246061
Research payments
$1,157,496
Through program year 2023, $1,157,496 in research payments was reported against Intracept, across 204 payments, paid by Relievant Medsystems, Inc..
- Paid by
- Relievant Medsystems, Inc.
- ClinicalTrials.gov
- NCT03246061
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $52,320 | 58 |
| 2022 | Research | $27,466 | 33 |
| 2021 | Research | $58,276 | 48 |
| 2020 | Research | $61,460 | 25 |
| 2019 | Research | $957,973 | 40 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Dan Nguyen Oklahoma City, OK Named on 18 payments
- Matthew Smuck Redwood City, CA Named on 16 payments
- John Keel Atlanta, GA Named on 16 payments
- Douglas Beall Edmond, OK Named on 13 payments
- Neel Anand Los Angeles, CA Named on 13 payments
- Jad Khalil Southfield, MI Named on 12 payments
- Larry Shannon Cooperstown, NY Named on 11 payments
- John Markman Rochester, NY Named on 11 payments
- Bradly Goodman Birmingham, AL Named on 10 payments
- Bruce Vrooman Lebanon, NH Named on 10 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.